Publications

Explore our publications to find useful evidence, lessons and recommendations from our work across Africa and Asia

SIGN UP TO THE PUBLICATIONS NEWSLETTER
Reset all search optionsCurrent search filters (53 results match ALL terms):
Burkina Faso
25/04/2022 Annual review Coverage and quality of seasonal malaria chemoprevention supported by Malaria Consortium in 2021: Results from Burkina Faso, Chad, Mozambique, Nigeria, Togo, and Uganda This report outlines methods employed by Malaria Consortium for monitoring coverage of its seasonal malaria chemoprevention (SMC) programme and the quality of SMC delivery in 2021. 25/04/2022 This report outlines methods employed by Malaria Consortium for monitoring coverage of its seasonal malaria chemoprevention (SMC) programme and the quality of SMC delivery in 2021.
25/04/2022 Annual review Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2021 This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC. 25/04/2022 This report summarises achievements and challenges in areas where Malaria Consortium used philanthropic funding for SMC.
12/04/2022 Capacity statement Social and behaviour change We implement evidence-based malaria SBC activities to promote community engagement, combat targeted diseases, improve public health outcomes and promote universal health coverage across Africa and Asia. 12/04/2022 We implement evidence-based malaria SBC activities to promote community engagement, combat targeted diseases, improve public health outcomes and promote universal health coverage across Africa and Asia.
04/02/2022 Technical brief Monitoring and evaluating seasonal malaria chemoprevention using a logical framework approach Malaria Consortium has developed a comprehensive framework for monitoring and evaluating seasonal malaria chemoprevention (SMC) programmes. 04/02/2022 Malaria Consortium has developed a comprehensive framework for monitoring and evaluating seasonal malaria chemoprevention (SMC) programmes.
20/11/2021 Poster Impact of seasonal malaria chemoprevention on the prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria The impact of SMC can be seen in malaria infection prevalence data collected through regular household surveys. 20/11/2021 The impact of SMC can be seen in malaria infection prevalence data collected through regular household surveys.
16/11/2021 Poster Factors predicting adherence to day two and day three seasonal malaria chemoprevention administration in four Sahelian countries Home visits by lead mothers and sensitisation about SMC dates and medicines can enhance caregiver adherence to administration of amodiaquine. 16/11/2021 Home visits by lead mothers and sensitisation about SMC dates and medicines can enhance caregiver adherence to administration of amodiaquine.
16/11/2021 Poster Exploring a role model approach to improve caregiver administration of seasonal malaria chemoprevention drugs to children under five in Burkina Faso, Chad and Togo The role model approach provides valuable insights to support improved caregiver administration of seasonal malaria chemoprevention drugs. 16/11/2021 The role model approach provides valuable insights to support improved caregiver administration of seasonal malaria chemoprevention drugs.
16/11/2021 Poster Adaptation of rapid multi-objective LQAS surveys in Burkina Faso, Chad, Nigeria, Mozambique and Togo to drive improvements in SMC delivery Lot quality assurance sampling (LQAS) was successfully used to rapidly improve use of data and facilitate decision-making for programme improvements in SMC-implementing countries. 16/11/2021 Lot quality assurance sampling (LQAS) was successfully used to rapidly improve use of data and facilitate decision-making for programme improvements in SMC-implementing countries.
11/10/2021 Synopsis Utiliser l’approche du modèle de comportement afin d’améliorer l’administration de médicaments pour la chimioprévention du paludisme saisonnier au Burkina Faso, au Tchad et au Togo Depuis 2013, Malaria Consortium est l’un des principaux acteurs de la mise en œuvre de la chimioprévention du paludisme saisonnier. Nous avons aidé des programmes nationaux de lutte contre le… 11/10/2021 Depuis 2013, Malaria Consortium est l’un des principaux acteurs de la mise en œuvre de la chimioprévention du paludisme saisonnier. Nous avons aidé des programmes nationaux de lutte contre le paludisme dans tout le Sahel.
09/09/2021 Synopsis Using the role model approach to improve administration of seasonal malaria chemoprevention drugs in Burkina Faso, Chad and Togo To adapt to the COVID-19 pandemic, caregivers administered three doses of the antimalarial drug SPAQ to minimise physical contact between community distributors and children. This synopsis looks at why this… 09/09/2021 To adapt to the COVID-19 pandemic, caregivers administered three doses of the antimalarial drug SPAQ to minimise physical contact between community distributors and children. This synopsis looks at why this approach was challenging for many caregivers.
08/09/2021 Journal article Effectiveness of seasonal malaria chemoprevention (SMC) treatments when SMC is implemented at scale: Case-control studies in five countries This study found that SMC was highly effective in preventing clinical malaria when delivered at scale through national malaria control programmes. This case-control design can be used by national malaria… 08/09/2021 This study found that SMC was highly effective in preventing clinical malaria when delivered at scale through national malaria control programmes. This case-control design can be used by national malaria control programmes at intervals to confirm that SMC remains effective.
10/06/2021 Learning paper Mettre en œuvre des campagnes de masse pendant une pandémie: Enseignements tirés du soutien à la chimioprévention du paludisme saisonnier pendant la COVID-19 Malaria Consortium a soutenu des programmes de chimioprévention du paludisme saisonnier au Burkina Faso, au Tchad, au Nigeria, au Togo et au Mozambique. 10/06/2021 Malaria Consortium a soutenu des programmes de chimioprévention du paludisme saisonnier au Burkina Faso, au Tchad, au Nigeria, au Togo et au Mozambique.
10/06/2021 Learning paper Implementação de campanhas em massa durante uma pandemia: Lições do apoio à quimioprevenção sazonal da malária durante a COVID-19 Malaria Consortium apoiou a quimioprevenção sazonal da malária no Burquina Faso, Chade, Nigéria, Togo e Moçambique, beneficiando a mais de 12 milhões de crianças 3–59 meses. 10/06/2021 Malaria Consortium apoiou a quimioprevenção sazonal da malária no Burquina Faso, Chade, Nigéria, Togo e Moçambique, beneficiando a mais de 12 milhões de crianças 3–59 meses.
09/06/2021 Brochure Malaria Consortium Burkina Faso We are carrying out seasonal malaria chemoprevention programmes across Burkina Faso and are exploring the potential of digital solutions to strengthen health systems in the country. 09/06/2021 We are carrying out seasonal malaria chemoprevention programmes across Burkina Faso and are exploring the potential of digital solutions to strengthen health systems in the country.
09/06/2021 Brochure Malaria Consortium Burkina Faso Depuis 2015, nous soutenons le Programme National de Lutte contre le Paludisme dans le cadre du renforcement par étapes de la CPS, en assurant la couverture des 70 districts sanitaires… 09/06/2021 Depuis 2015, nous soutenons le Programme National de Lutte contre le Paludisme dans le cadre du renforcement par étapes de la CPS, en assurant la couverture des 70 districts sanitaires du Burkina Faso.
02/06/2021 Project brief Chimioprévention du paludisme saisonnier: Protéger les enfants de moins de cinq ans contre le paludisme durant les pics de transmission saisonniers En 2021, notre programme vise à atteindre 20 millions d’enfants au Burkina Faso, au Tchad, au Nigéria et au Togo. Nous poursuivrons nos recherches au Mozambique et lancerons une étude… 02/06/2021 En 2021, notre programme vise à atteindre 20 millions d’enfants au Burkina Faso, au Tchad, au Nigéria et au Togo. Nous poursuivrons nos recherches au Mozambique et lancerons une étude de même type en Ouganda.
02/06/2021 Project brief Quimioprevenção sazonal da malária: Proteger os menores de cinco anos contra a malária durante a época alta de transmissão Em 2021, o nosso programa tem como objectivo alcançar 20 milhões de crianças no Burquina Faso, Chade, Nigéria e Togo. Prosseguiremos a nossa investigação em Moçambique e iniciaremos um estudo… 02/06/2021 Em 2021, o nosso programa tem como objectivo alcançar 20 milhões de crianças no Burquina Faso, Chade, Nigéria e Togo. Prosseguiremos a nossa investigação em Moçambique e iniciaremos um estudo semelhante no Uganda.
13/05/2021 Project brief Seasonal malaria chemoprevention: Protecting children under five from malaria during peak transmission season In 2021, Malaria Consortium's SMC programme aims to reach 20 million children in Burkina Faso, Chad, Nigeria and Togo. We will continue our research in Mozambique and have started a… 13/05/2021 In 2021, Malaria Consortium's SMC programme aims to reach 20 million children in Burkina Faso, Chad, Nigeria and Togo. We will continue our research in Mozambique and have started a similar study in Uganda.
29/04/2021 Learning paper Implementing mass campaigns during a pandemic: What we learnt from supporting seasonal malaria chemoprevention during COVID-19 Key learnings from supporting seasonal malaria chemoprevention implementation during the pandemic while following strict infection prevention and control guidelines, give invaluable insights that can inform future SMC implementation. 29/04/2021 Key learnings from supporting seasonal malaria chemoprevention implementation during the pandemic while following strict infection prevention and control guidelines, give invaluable insights that can inform future SMC implementation.
16/04/2021 Annual review Quantitative report on seasonal malaria chemoprevention supported by Malaria Consortium in 2020: Coverage and quality in Burkina Faso, Chad, Nigeria and Togo This report outlines methods employed by Malaria Consortium for monitoring coverage of its seasonal malaria chemoprevention programme and the quality of SMC delivery in 2020. 16/04/2021 This report outlines methods employed by Malaria Consortium for monitoring coverage of its seasonal malaria chemoprevention programme and the quality of SMC delivery in 2020.
16/04/2021 Annual review Malaria Consortium’s seasonal malaria chemoprevention program: Philanthropy report 2020 Malaria Consortium’s annual report on the use of philanthropic funding for seasonal malaria chemoprevention. 16/04/2021 Malaria Consortium’s annual report on the use of philanthropic funding for seasonal malaria chemoprevention.
29/01/2021 Journal article Seasonal malaria chemoprevention in the Sahel subregion of Africa: A cost-effectiveness and cost-savings analysis This study provides timely and important evidence on the cost, cost-effectiveness and potential cost savings of the first large-scale, multi-country seasonal malaria chemoprevention campaign. 29/01/2021 This study provides timely and important evidence on the cost, cost-effectiveness and potential cost savings of the first large-scale, multi-country seasonal malaria chemoprevention campaign.
05/12/2020 Journal article Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: An observational study This study evaluates the ACCESS-SMC project, which sought to remove barriers to SMC scale-up in seven countries in 2015–2016. These results represent the first large-scale evaluation of SMC implemented by… 05/12/2020 This study evaluates the ACCESS-SMC project, which sought to remove barriers to SMC scale-up in seven countries in 2015–2016. These results represent the first large-scale evaluation of SMC implemented by national programmes, and provide evidence of impact on malaria deaths.
18/11/2020 Presentation Extending seasonal malaria chemoprevention to five cycles: A feasibility and acceptability study in Cascades region, Burkina Faso This presentation examines the feasibility and accpetability of extending seasonal malaria chemoprevention to five cycles in Cascades region, Burkina Faso. It was given at the 69th annual meeting of the… 18/11/2020 This presentation examines the feasibility and accpetability of extending seasonal malaria chemoprevention to five cycles in Cascades region, Burkina Faso. It was given at the 69th annual meeting of the American Society of Tropical Medicine & Hygiene.
18/11/2020 Presentation An ecological analysis exploring the impact of seasonal malaria chemoprevention in Burkina Faso using national household surveys (2010–2017)​ This presentation was given at the 69th annual meeting of the American Society of Tropical Medicine and Hygiene. It investigates whether the effect of seasonal malaria chemoprevention (SMC) can be… 18/11/2020 This presentation was given at the 69th annual meeting of the American Society of Tropical Medicine and Hygiene. It investigates whether the effect of seasonal malaria chemoprevention (SMC) can be observed in household data, and to add to the evidence…
02/11/2020 Synopsis Assessing adherence to infection prevention and control measures for seasonal malaria chemoprevention during COVID-19 This study will explore community distributors’ adherence to infection prevention and control practices for seasonal malaria chemoprevention during the COVID-19 pandemic in Burkina Faso, Chad and Nigeria. 02/11/2020 This study will explore community distributors’ adherence to infection prevention and control practices for seasonal malaria chemoprevention during the COVID-19 pandemic in Burkina Faso, Chad and Nigeria.
19/10/2020 Synopsis Designing and implementing a monitoring and evaluation framework for seasonal malaria chemoprevention Malaria Consortium is developing monitoring and evaluation framework for seasonal malaria chemoprevention with standardised indicators across countries to facilitate appraisal of the quality of programme delivery. 19/10/2020 Malaria Consortium is developing monitoring and evaluation framework for seasonal malaria chemoprevention with standardised indicators across countries to facilitate appraisal of the quality of programme delivery.
06/05/2020 Learning brief Mise en place de la chimioprévention du paludisme saisonnier en milieu urbain En 2019, notre programme de la chimioprévention du paludisme saisonnier (CPS) s’est déroulé à la fois en milieu rural et urbain du Burkina Faso, dans le cadre politique nationale de… 06/05/2020 En 2019, notre programme de la chimioprévention du paludisme saisonnier (CPS) s’est déroulé à la fois en milieu rural et urbain du Burkina Faso, dans le cadre politique nationale de parvenir à une couverture totale du pays en distribuant la…
05/05/2020 Annual review Seasonal malaria chemoprevention program Philanthropy Report 2019-2020 Malaria Consortium’s annual report on the use of philanthropic funding for seasonal malaria chemoprevention 05/05/2020 Malaria Consortium’s annual report on the use of philanthropic funding for seasonal malaria chemoprevention
24/03/2020 Learning brief Implementing seasonal malaria chemoprevention in an urban setting In 2019, our seasonal malaria chemoprevention programme took place in Burkina Faso's rural and urban settings. In Ouagadougou, we adapted to socio-economic differences and rapid urbanisation to ensure effective campaign… 24/03/2020 In 2019, our seasonal malaria chemoprevention programme took place in Burkina Faso's rural and urban settings. In Ouagadougou, we adapted to socio-economic differences and rapid urbanisation to ensure effective campaign delivery.
07/11/2019 Journal article Institutionalisation of integrated community case management into national health systems in low- and middle-income countries: A scoping review of the literature Background Integrated community case management (iCCM) for malaria, pneumonia and diarrhoea continues to be a recommended strategy to address child mortality in areas where access to health facilities is limited. Objective To identify… 07/11/2019 Background Integrated community case management (iCCM) for malaria, pneumonia and diarrhoea continues to be a recommended strategy to address child mortality in areas where access to health facilities is limited. Objective To identify models of, and gaps in, institutionalisation of benchmark components of…
28/01/2019 Learning paper Seasonal chemoprevention as an effective malaria preventive strategy for children in the Sahel This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) project, which was launched in 2015 to overcome barriers to seasonal… 28/01/2019 This paper shares learning and recommendations from the Achieving Catalytic Expansion of Seasonal Malaria Chemoprevention in the Sahel (ACCESS-SMC) project, which was launched in 2015 to overcome barriers to seasonal malaria chemoprevention (SMC) scale-up. By supporting national malaria control/elimination programmes…
11/12/2018 Annual review Trustees' report and financial statements for the year to 31 March 2018 Malaria Consortium's Trustees present their report and the audited financial statements for the year which ended 31 March 2018. 11/12/2018 Malaria Consortium's Trustees present their report and the audited financial statements for the year which ended 31 March 2018.
21/09/2018 Advocacy brief Malaria Consortium and the Sustainable Development Goals At Malaria Consortium, we strive to ensure that our work contributes to achieving the Global Goals for Sustainable Development (SDGs) by 2030. We support the countries in which we operate… 21/09/2018 At Malaria Consortium, we strive to ensure that our work contributes to achieving the Global Goals for Sustainable Development (SDGs) by 2030. We support the countries in which we operate to ensure their citizens are free from the burden of…
30/08/2018 Infographic Impact: Malaria Consortium and seasonal malaria chemoprevention Malaria Consortium has been distributing preventive treatments to children under five across the Sahel region to protect them from malaria during the past four rainy seasons. Case-control studies have found… 30/08/2018 Malaria Consortium has been distributing preventive treatments to children under five across the Sahel region to protect them from malaria during the past four rainy seasons. Case-control studies have found that one treatment course of seasonal malaria chemoprevention (SMC) per…
04/05/2018 Presentation Scaling up access to seasonal malaria chemoprevention in the Sahel Diego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at the 2018 Multilateral Initiative on Malaria cConference. There is an… 04/05/2018 Diego Moroso, Project Director for ACCESS-SMC, presented the feasibility, safety and effectiveness of seasonal malaria chemoprevention (SMC) at scale at the 2018 Multilateral Initiative on Malaria cConference. There is an estimated gap of 12 to 18 million children who could…
05/03/2018 Case study Le récit de Bénédicte: “Mes enfants ne tombent plus malades pendant la saison des pluies. Je peux désormais économiser un peu d’argent.” ACCESS-SMC est un projet sur trois ans, financé par UNITAID, qui soutient les Programmes Nationaux de Lutte contre le Paludisme pour mener à bien le premier déploiement à grande échelle… 05/03/2018 ACCESS-SMC est un projet sur trois ans, financé par UNITAID, qui soutient les Programmes Nationaux de Lutte contre le Paludisme pour mener à bien le premier déploiement à grande échelle de la Chimioprévention du paludisme saisonnier (CPS) et ainsi sauver…
28/02/2018 Newsletter A catalyst project comes to an end Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and save children’s… 28/02/2018 Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention and save children’s lives across seven countries in the Sahel. This final newsletter…
02/02/2018 Case study Bénédicte’s story: “My children do not get sick during the rainy season anymore.” This case study from Burkina Faso highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria… 02/02/2018 This case study from Burkina Faso highlights the impact of seasonal malaria chemoprevention. Through ACCESS-SMC — a three-year UNITAID-funded project — Malaria Consortium and Catholic Relief Services supported National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention…
29/11/2017 Project brief Sauver des vies – la CPS à grande échelle Le paludisme est une maladie prévisible et traitable, mais de nombreux enfants en Afrique en meurent avant leur cinquième anniversaire. Le projet ACCESS-SMC a prouvé la faisabilité et l’impact la… 29/11/2017 Le paludisme est une maladie prévisible et traitable, mais de nombreux enfants en Afrique en meurent avant leur cinquième anniversaire. Le projet ACCESS-SMC a prouvé la faisabilité et l’impact la chimioprévention du paludisme saisonnier (CPS) à grande échelle. La CPS,…
22/11/2017 Poster Transforming the malaria landscape: Results from a three-year implementation research project expanding access to seasonal malaria chemoprevention in seven Sahelian countries Malaria Consortium presented a poster detailing the results from the three-year ACCESS-SMC project at the 10th European Congress on Tropical Medicine and International Health in Antwerp, Belgium from 16–20 October… 22/11/2017 Malaria Consortium presented a poster detailing the results from the three-year ACCESS-SMC project at the 10th European Congress on Tropical Medicine and International Health in Antwerp, Belgium from 16–20 October 2017. The project focused on expanding access to seasonal malaria…
13/11/2017 Technical brief Seasonal malaria chemoprevention at scale: Saving lives Malaria is preventable and treatable, but many children in Africa still die from malaria before their fifth birthday. The ACCESS-SMC project has proven the feasibility, safety and effectiveness of seasonal… 13/11/2017 Malaria is preventable and treatable, but many children in Africa still die from malaria before their fifth birthday. The ACCESS-SMC project has proven the feasibility, safety and effectiveness of seasonal malaria chemoprevention at scale. An estimated gap of 12 to…
17/10/2017 Annual review Trustees' report and financial statements for the year to 31 March 2017 Malaria Consortium's Trustees present their report and the audited financial statements for the year which ended 31 March 2017. 17/10/2017 Malaria Consortium's Trustees present their report and the audited financial statements for the year which ended 31 March 2017.
29/09/2017 Newsletter ACCESS-SMC September 2017 newsletter Malaria Consortium has achieved high coverage of seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. In Burkina Faso and Chad we are even reaching more children than initially targeted.… 29/09/2017 Malaria Consortium has achieved high coverage of seasonal malaria chemoprevention in Burkina Faso, Chad and Nigeria. In Burkina Faso and Chad we are even reaching more children than initially targeted. Read about the major strides the ACCESS-SMC project is making…
31/07/2017 Case study Reaching all children, no matter what ACCESS-SMC is a three-year UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services, which is supporting National Malaria Control Programmes to scale up access to seasonal malaria… 31/07/2017 ACCESS-SMC is a three-year UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services, which is supporting National Malaria Control Programmes to scale up access to seasonal malaria chemoprevention across seven countries in the Sahel. This case study…
29/06/2017 Newsletter ACCESS-SMC June 2017 newsletter ACCESS-SMC brought together leaders in malaria prevention to reach over 6.4 million children in seven countries across the Sahel in 2016. This year, ACCESS-SMC will implement one last season to… 29/06/2017 ACCESS-SMC brought together leaders in malaria prevention to reach over 6.4 million children in seven countries across the Sahel in 2016. This year, ACCESS-SMC will implement one last season to reach roughly 3.9 million children in Burkina Faso, Chad and…
03/02/2017 Annual review Malaria Consortium strategy 2015–2019 To achieve our mission, Malaria Consortium will work with partners — including all levels of government — to improve the lives of all in Africa and Asia, especially the poorest… 03/02/2017 To achieve our mission, Malaria Consortium will work with partners — including all levels of government — to improve the lives of all in Africa and Asia, especially the poorest and most marginalised. We will target key health burdens, including…
10/01/2017 Learning brief Seasonal malaria chemoprevention: Transforming the malaria landscape in the Sahel ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. This learning brief discusses the project’s approach to scaling up seasonal malaria chemoprevention (SMC) and… 10/01/2017 ACCESS-SMC is a UNITAID-funded project, led by Malaria Consortium in partnership with Catholic Relief Services. This learning brief discusses the project’s approach to scaling up seasonal malaria chemoprevention (SMC) and its impact on reducing malaria in children under five across…
20/11/2016 Annual review Trustees report and financial statements for the year to 31 March 2016 Take a look at Malaria Consortium's trustees report and financial statements for the year that ended 31 March 2016. Also read the highlights from the trustees report and financial statements… 20/11/2016 Take a look at Malaria Consortium's trustees report and financial statements for the year that ended 31 March 2016. Also read the highlights from the trustees report and financial statements 2015–2016.
20/11/2016 Annual review Highlights from the trustees report and financial statements 2015–2016 During the first operating year of Malaria Consortium’s 2015–2019 strategy, we continued to deliver on our mission to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat… 20/11/2016 During the first operating year of Malaria Consortium’s 2015–2019 strategy, we continued to deliver on our mission to improve lives in Africa and Asia through sustainable, evidence-based programmes that combat targeted diseases and promote child and maternal health. This review…
08/06/2016 Advocacy brief Making the case for seasonal malaria chemoprevention Seasonal malaria chemoprevention (SMC) is a highly effective method of malaria prevention, recommended by the World Health Organization. This advocacy brief makes the case for scaling up SMC across the… 08/06/2016 Seasonal malaria chemoprevention (SMC) is a highly effective method of malaria prevention, recommended by the World Health Organization. This advocacy brief makes the case for scaling up SMC across the Sahel region, discusses the challenges to successful scale-up, and presents…
15/12/2015 Annual review Annual review: Highlights of the year 2014–2015 In 2014–2015, we continued our work to reduce malaria deaths and incidence by helping governments tailor, innovate, adopt and apply interventions best suited to their needs. We also supported the… 15/12/2015 In 2014–2015, we continued our work to reduce malaria deaths and incidence by helping governments tailor, innovate, adopt and apply interventions best suited to their needs. We also supported the delivery of integrated community case management programmes, extended our engagement…
07/11/2012 Journal article Integrated Community Case Management of Fever in Children under Five Using Rapid Diagnostic Tests and Respiratory Rate Counting: A Multi-Country Cluster Randomized Trial Abstract Evidence on the impact of using diagnostic tests in community case management of febrile children is limited. This effectiveness trial conducted in Burkina Faso, Ghana, and Uganda, compared a diagnostic… 07/11/2012 Abstract Evidence on the impact of using diagnostic tests in community case management of febrile children is limited. This effectiveness trial conducted in Burkina Faso, Ghana, and Uganda, compared a diagnostic and treatment package for malaria and pneumonia with presumptive treatment…
View all publications

Sign up for our newsletters here: